| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Mereo BioPharma Group (NASDAQ:MREO) through any online brokerage.
Other companies in Mereo BioPharma Group’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Mereo BioPharma Group has a consensus price target of $4.58.
The stock price for Mereo BioPharma Group (NASDAQ: MREO) is $0.2868 last updated October 22, 2026 at 9:07 AM EDT.
There are no upcoming dividends for Mereo BioPharma Group.
Mereo BioPharma Group does not have any upcoming earnings scheduled.
There is no upcoming split for Mereo BioPharma Group.
Mereo BioPharma Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
